Literature DB >> 7130931

Cyclophosphamide-induced leukopenia and suppression of limb regeneration in the adult newt, notophthalmus viridescens.

O E Schotté, R E Sicard.   

Abstract

Cyclophosphamide (cytoxan), a clinical immunosuppressant, produced a marked, persistent leukopenia (greater than 40% reduction) in adult newts in contrast to a transient, milder leukopenia accompanying amputations without cytoxan treatments. In addition, cytoxan suppressed the formation of regeneration blastemata initially: however, blastema formation occurred if a second amputation was performed two or more weeks following the cessation of cytoxan treatments. The failure of the leukopenias of these latter cases to be corrected suggests that although a cytoxan-induced leukopenia is correlated with the absence of forelimb regeneration, this leukopenia is not, of itself, a sufficient condition to inhibit regeneration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130931     DOI: 10.1002/jez.1402220212

Source DB:  PubMed          Journal:  J Exp Zool        ISSN: 0022-104X


  4 in total

1.  Macrophages are required for adult salamander limb regeneration.

Authors:  James W Godwin; Alexander R Pinto; Nadia A Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

2.  Stress and changes in the blood of newts, Notophthalmus viridescens, during early regeneration.

Authors:  M F Bennett
Journal:  J Comp Physiol A       Date:  1986-12       Impact factor: 1.836

3.  Distinct toll-like receptor signaling in the salamander response to tissue damage.

Authors:  Ryan J Debuque; Sergej Nowoshilow; Katya E Chan; Nadia A Rosenthal; James W Godwin
Journal:  Dev Dyn       Date:  2021-04-08       Impact factor: 2.842

4.  Complex Tissue Regeneration in Mammals Is Associated With Reduced Inflammatory Cytokines and an Influx of T Cells.

Authors:  Thomas R Gawriluk; Jennifer Simkin; Corin K Hacker; John M Kimani; Stephen G Kiama; Vanessa O Ezenwa; Ashley W Seifert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.